Now your mammogram can provide insight into your breast and heart health in
one exam.

Bring added heart health value to every mammogram at your practice.

Onsite’s Mammo with heart program enables your patients’ routine screening mammograms to deliver insight into both breast and heart health—without adding time, appointments or workflow burden.

Breast Arterial Calcifications (BAC) are calcium buildups in the breast’s arteries and may be an indicator of cardiovascular disease in women. With Mammo with heart, powered by cmAngio® by CureMetrix®, advanced AI analyzes screening mammograms to identify the presence of BAC—providing additional clinical insight at the point of care.

How Breast Arterial Calcification Impacts Your Health

0 %
Increase in risk of heart disease or stroke¹

0 x
Increase in cardiovascular event-specific death²

0 %
of women aged 60–79 have arterial calcification³

1 American Heart Association, Mammograms may provide clues about women’s risk for cardiovascular disease.

2 National Library of Medicine, Relationship between arterial calcification on mammograms and cardiovascular events.

3 National Library of Medicine, Relationship between arterial calcification on mammograms and cardiovascular events.

Key facts about Mammo with heart

  • FDA-cleared, AI-based detection software for identifying the presence of Breast Arterial Calcifications (BAC) in mammograms
  • Works from a patient’s mammogram
  • BACs are linked to an increased risk of heart disease and stroke, making detection crucial for patient health
  • Determine if further evaluation is recommended
  • No additional effort for the patient 
  • No additional radiation

Frequently Asked Questions

Mammo with heart is an enhancement to traditional screening mammography that uses FDA-cleared, AI-based software – cmAngio® by CureMetrix® – to identify the presence of Breast Arterial Calcifications (BAC) on a mammogram.

Yes, the breast arterial calcification detection software that Onsite Women’s Health uses is FDA-cleared.

Breast Arterial Calcifications (BAC) is a calcium build-up in the arteries of the breast. The calcium deposition leads to arterial stiffening and increased pressure on the vessel walls. This is regularly observed on screening mammography.

Based on current research and published literature, Breast Arterial Calcifications (BAC) is currently considered to be a benign incidental finding without defined clinical importance to breast cancer screening. However, there is growing evidence that it is associated with other vascular calcifications and associated clinical outcomes. Patients identified with BAC may be candidates for additional clinical evaluation of general health.

The cmAngio software reads the patient’s mammogram to determine the presence or absence of breast arterial calcification. One of Onsite’s radiologists will review the results to confirm the findings.

No, with cmAngio, a screening mammogram serves as a two-for-one exam with no additional screening and no additional radiation.

We recommend your patient repeat the screening every year with her annual mammogram.

All women may benefit from a Mammo with heart assessment regardless of their age. Identifying risk factors for their health is important at any age.

Patients with breast implants or any other devices in the chest, such as pacemakers, should not opt-in for Mammo with heart.

Mammo with heart is optional but is not yet covered by insurance. Therefore, any patient who opts in will pay out of pocket for the additional study. The current price will be set by the practice.

Contact us for more information.